Earlier in the week, I wrote about a cancer vaccine treatment that Stanford pathologist Edgar Engleman, MD, developed in the early 90s. As expected, the FDA gave the vaccine, called Provenge, the thumbs up today; according to Dow Jones (subscription required), the agency approved Provenge for patients with advanced prostate cancer who have failed hormone therapy treatment.
Popular posts
A skeptical look at popular diets: How ketogenic should you go?
In the fourth post in the series A Skeptical Look at Popular Diets, physician Randall Stafford examines pros and cons of a ketogenic diet.
An honest answer to the question “How’s medical school?”
In this Stanford Medicine Unplugged piece, a first-year student shares the more difficult aspects of medical school.